(2E,4E,6Z,8E)-3,7-Dimethyl-9-((1S,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-en-2-yl)-2,4,6,8-nonatetraenoic acid

ID: ALA1773356

PubChem CID: 54585065

Max Phase: Preclinical

Molecular Formula: C21H28O2

Molecular Weight: 312.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=C/C=C/C(C)=C/C(=O)O)/C=C/C1=C[C@@H]2CC[C@@]1(C)C2(C)C

Standard InChI:  InChI=1S/C21H28O2/c1-15(7-6-8-16(2)13-19(22)23)9-10-18-14-17-11-12-21(18,5)20(17,3)4/h6-10,13-14,17H,11-12H2,1-5H3,(H,22,23)/b8-6+,10-9+,15-7-,16-13+/t17-,21+/m0/s1

Standard InChI Key:  OLTHLBHNRAIYMD-AWRNQUDUSA-N

Molfile:  

     RDKit          2D

 24 25  0  0  0  0  0  0  0  0999 V2000
   -1.6312    1.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9146    1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6312    0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3437    1.6583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2021    1.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6479   -1.2458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6479   -2.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2229    0.4083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9354   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5104    1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9354   -0.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2229    1.2333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3604   -2.4833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3437    0.0083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0521    1.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0521    0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2187   -1.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5187    2.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5604    0.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3604    1.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3604    0.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3479    2.4833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3437   -0.8167    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.9312   -2.4792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  2  0
  4  1  1  0
  5  2  2  0
  6  9  2  0
  7  6  1  0
  8 12  1  0
  9 11  1  0
 10  5  1  0
 11  8  2  0
 12 10  2  0
 13  7  2  0
 14  3  1  0
 15  4  1  0
 16 15  1  0
 17  9  1  0
 18 10  1  0
 14 16  1  0
  4 19  1  0
 14 19  1  0
 19 20  1  0
 19 21  1  0
  4 22  1  1
 14 23  1  1
  7 24  1  0
M  END

Associated Targets(Human)

RARB Tclin Retinoic acid receptor beta (1232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Crabp2 Cellular retinoic acid-binding protein II (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 312.45Molecular Weight (Monoisotopic): 312.2089AlogP: 5.46#Rotatable Bonds: 5
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.76CX Basic pKa: CX LogP: 4.74CX LogD: 2.15
Aromatic Rings: Heavy Atoms: 23QED Weighted: 0.54Np Likeness Score: 2.08

References

1. Okitsu T, Sato K, Iwatsuka K, Sawada N, Nakagawa K, Okano T, Yamada S, Kakuta H, Wada A..  (2011)  Replacement of the hydrophobic part of 9-cis-retinoic acid with cyclic terpenoid moiety results in RXR-selective agonistic activity.,  19  (9): [PMID:21489804] [10.1016/j.bmc.2011.03.033]

Source